Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases.
about
Scn3b knockout mice exhibit abnormal ventricular electrophysiological propertiesElectrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores.Facts, fancies and follies of drug-induced QT/QTc interval shortening.Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of atrial arrhythmogenesis in murine Langendorff-perfused hearts.Delayed conduction and its implications in murine Scn5a(+/-) hearts: independent and interacting effects of genotype, age, and sexEpac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart.Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis.Continuous and discontinuous propagation in heart muscle.Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart.Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts.Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome.Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse heartsMurine Electrophysiological Models of Cardiac Arrhythmogenesis.Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model.Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.Alternans in genetically modified langendorff-perfused murine hearts modeling catecholaminergic polymorphic ventricular tachycardia.Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis.Transient alterations in transmural repolarization gradients and arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts.
P2860
Q24651316-6575384E-D6CA-4901-8E77-9BC1867761BCQ28507803-16109480-ECA3-4382-98B8-36484D26EB9BQ28587543-FA3A99E3-A8C4-4A7F-BB46-4B0A7AF5D94EQ33514742-E6A8DA87-DFF9-4AE9-9558-3ECCED800115Q33661036-63834C8F-8257-48A0-BB47-67A0AEDE7D98Q33739827-5D9D7B7C-145E-4DFF-8806-E50D889052C5Q34467730-94E0D47B-6D49-490B-8656-45A5B7231951Q34792255-964021C0-F794-4A84-8459-9D217DA7DDCAQ35768779-EB222E34-B46B-4B76-BB4D-0220B4C32090Q36088707-A8337F5A-2DFC-4FAB-A5A0-F49973631E47Q36473119-9416D0C9-F042-4029-91D5-9BE966603CB8Q36590790-2FB05AD1-9632-429F-8CCC-E9EAA834B679Q36627790-D12931A2-503A-4A58-91A8-6856A176824FQ37066411-37C03B4B-D906-447E-943B-2D1D227A8432Q37214708-78AD488F-E709-4AFA-A131-39747AE94A17Q37286117-EFD44AA8-BD73-43B2-96AD-6847C35B1E65Q38719030-BDD9CA99-F7DD-4518-BF41-AA5A8A961E3DQ39038606-7AD7D327-B49D-4F3A-82AF-BA3980BED8F6Q39814350-F861D72B-46EC-4655-A9C7-D3C7A5EC0BBDQ40263183-62244DBE-D570-4FC1-AFF8-B00B467E5D47Q41774118-F2A9FC65-A9E2-461B-B9AF-AA841C633DB8Q42699881-80B9640D-FF76-4185-969F-AD300F44AF5CQ42973532-ADFC183D-E8BC-4381-BB73-2762A5385E7EQ46516420-B6580242-A7E9-44A0-BE9A-1F0A3CA8E69DQ48616999-16FA76D0-3EF2-4EAD-A67A-E56385F2F91B
P2860
Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Paced ventricular electrogram ...... r non-coronary heart diseases.
@ast
Paced ventricular electrogram ...... r non-coronary heart diseases.
@en
type
label
Paced ventricular electrogram ...... r non-coronary heart diseases.
@ast
Paced ventricular electrogram ...... r non-coronary heart diseases.
@en
prefLabel
Paced ventricular electrogram ...... r non-coronary heart diseases.
@ast
Paced ventricular electrogram ...... r non-coronary heart diseases.
@en
P1476
Paced ventricular electrogram ...... r non-coronary heart diseases.
@en
P2093
P356
10.1016/S0008-6363(00)00096-1
P577
2000-07-01T00:00:00Z